Nanonization of Megestrol Acetate by Liquid Precipitation

被引:45
|
作者
Zhang, Zhi-Bing [1 ]
Shen, Zhi-Gang [1 ]
Wang, Jie-Xin [1 ]
Zhao, Hong [1 ]
Chen, Jian-Feng [2 ]
Yun, Jimmy [3 ]
机构
[1] Beijing Univ Chem Technol, Sin China Nano Technol Ctr, Key Lab Nanomat, Minist Educ, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Res Ctr, Minist Educ High Grav Engn & Technol, Beijing 100029, Peoples R China
[3] Nanomat Technol Pte Ltd, Singapore 139959, Singapore
基金
中国国家自然科学基金;
关键词
WATER-SOLUBLE DRUGS; ANTISOLVENT PRECIPITATION; NANOPARTICLES; NANOSUSPENSIONS; FORMULATION; DISSOLUTION; THERAPY;
D O I
10.1021/ie900944y
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The purpose of this study was to prepare megestrol acetate (MA) nanoparticles via a liquid precipitation technique. Several experimental parameters, such as the stabilizer combination, the volume ratio of antisolvent to drug solution, the temperature, the stirring speed, and the drying method were investigated. The as-prepared MA particles had a mean size of 208 nm, and 90% of the particles were distributed in the range of 100-300 nm, whereas the raw MA had a mean particle size of about 3.02 mu m, ranging widely from 0.2 mu m to 30,mu m. X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared (FTIR) analysis indicated that MA nanoparticles exhibited decreased crystallinity and unchanged chemical group structure after precipitation. The freeze-dried MA nanoparticles exhibited improved wettability as demonstrated by the contact angle measurement result proving that particles were covered by a hydrophilic layer. In dissolution rate tests, the nanoparticles achieved 100% drug dissolution within 5 min, while the raw MA did not dissolve completely after 120 min, suggesting that the dissolution property of MA nanoparticles was significantly enhanced.
引用
收藏
页码:8493 / 8499
页数:7
相关论文
共 50 条
  • [1] Nanonization of megestrol acetate by laser fragmentation in aqueous milieu
    Sylvestre, Jean-Philippe
    Tang, Marie-Christine
    Furtos, Alexandra
    Leclair, Gregoire
    Meunier, Michel
    Leroux, Jean-Christophe
    JOURNAL OF CONTROLLED RELEASE, 2011, 149 (03) : 273 - 280
  • [2] Megestrol acetate as a biomodulator
    Chang, AY
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 58 - 61
  • [3] MEGESTROL ACETATE GLUCURONIDATION
    Mirkov, S.
    Seminerio, M.
    Ramirez, J.
    House, L.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S71 - S71
  • [4] Precipitation Reaction of SDS and Potassium Salts in Flocculation of a Micronized Megestrol Acetate Suspension
    Hejazi, Seyed Mahdi
    Erfan, Mohammad
    Mortazavi, Seyed Alireza
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (03): : 239 - 246
  • [5] MEGESTROL-ACETATE
    CANETTA, R
    FLORENTINE, S
    HUNTER, H
    LENAZ, L
    CANCER TREATMENT REVIEWS, 1983, 10 (03) : 141 - 157
  • [6] In re megestrol acetate treatment
    Bennett, RG
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (03) : 339 - 339
  • [7] Antiemetic properties of megestrol acetate
    Loprinzi, C
    Jatoi, A
    JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (02) : 239 - 240
  • [8] EFFECT OF MEGESTROL ACETATE ON SICKLING
    ADADEVOH, BK
    ISAACS, WA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1973, 265 (05): : 367 - 370
  • [9] Megestrol acetate: Promises and pitfalls
    Farrar, DJ
    AIDS PATIENT CARE AND STDS, 1999, 13 (03) : 149 - 152
  • [10] Corticosteroid effects of megestrol acetate
    Leinung, M
    Koller, EA
    Fossler, MJ
    ENDOCRINOLOGIST, 1998, 8 (03): : 153 - 159